View in EDS

Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.

Saved in:
Bibliographic Details
Title: Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
Authors: Mariani LH; Renal Division, University of Michigan, Ann Arbor, Michigan. Electronic address: lmariani@umich.edu., Trachtman H; Department of Pediatrics/Nephrology, University of Michigan, Ann Arbor, Michigan. Electronic address: howardtrachtman21@gmail.com., Thompson A; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Gillespie BS; Fortrea, Durham, North Carolina; Kidney Center, University of North Carolina, Chapel Hill, North Carolina., Denburg M; Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Diva U; Travere Therapeutics, San Diego, California., Geetha D; School of Medicine, Johns Hopkins University, Baltimore, Maryland., Greasley PJ; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hladunewich MA; University of Toronto, Toronto, Ontario., Huizinga RB; Aurinia Pharmaceuticals, Victoria, British Columbia, Canada., Inrig JK; Travere Therapeutics, San Diego, California., Komers R; Travere Therapeutics, San Diego, California., Laurin LP; Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada., Little DJ; Clinical Development, Late Cardiovascular, Renal and Metabolism, AstraZeneca, Gaithersburg, Maryland., Nachman PH; University of Minnesota, Minneapolis, Minnesota., Smith KA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Walsh L; Goldfinch Bio, Boston, Massachusetts., Gibson KL; Kidney Center, University of North Carolina, Chapel Hill, North Carolina.
Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2025 May; Vol. 85 (5), pp. 610-617. Date of Electronic Publication: 2024 Oct 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6838 (Electronic) Linking ISSN: 02726386 NLM ISO Abbreviation: Am J Kidney Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39455047
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mariani+LH%22">Mariani LH</searchLink>; Renal Division, University of Michigan, Ann Arbor, Michigan. Electronic address: lmariani@umich.edu.<br /><searchLink fieldCode="AU" term="%22Trachtman+H%22">Trachtman H</searchLink>; Department of Pediatrics/Nephrology, University of Michigan, Ann Arbor, Michigan. Electronic address: howardtrachtman21@gmail.com.<br /><searchLink fieldCode="AU" term="%22Thompson+A%22">Thompson A</searchLink>; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Gillespie+BS%22">Gillespie BS</searchLink>; Fortrea, Durham, North Carolina; Kidney Center, University of North Carolina, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Denburg+M%22">Denburg M</searchLink>; Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Diva+U%22">Diva U</searchLink>; Travere Therapeutics, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Geetha+D%22">Geetha D</searchLink>; School of Medicine, Johns Hopkins University, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Greasley+PJ%22">Greasley PJ</searchLink>; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Hladunewich+MA%22">Hladunewich MA</searchLink>; University of Toronto, Toronto, Ontario.<br /><searchLink fieldCode="AU" term="%22Huizinga+RB%22">Huizinga RB</searchLink>; Aurinia Pharmaceuticals, Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Inrig+JK%22">Inrig JK</searchLink>; Travere Therapeutics, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Komers+R%22">Komers R</searchLink>; Travere Therapeutics, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Laurin+LP%22">Laurin LP</searchLink>; Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Little+DJ%22">Little DJ</searchLink>; Clinical Development, Late Cardiovascular, Renal and Metabolism, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Nachman+PH%22">Nachman PH</searchLink>; University of Minnesota, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Smith+KA%22">Smith KA</searchLink>; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.<br /><searchLink fieldCode="AU" term="%22Walsh+L%22">Walsh L</searchLink>; Goldfinch Bio, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gibson+KL%22">Gibson KL</searchLink>; Kidney Center, University of North Carolina, Chapel Hill, North Carolina.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228110075%22">American journal of kidney diseases : the official journal of the National Kidney Foundation</searchLink> [Am J Kidney Dis] 2025 May; Vol. 85 (5), pp. 610-617. <i>Date of Electronic Publication: </i>2024 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8110075 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-6838 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202726386%22">02726386 </searchLink><i>NLM ISO Abbreviation: </i>Am J Kidney Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39455047
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1053/j.ajkd.2024.08.011
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 610
    Titles:
      – TitleFull: Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mariani LH
      – PersonEntity:
          Name:
            NameFull: Trachtman H
      – PersonEntity:
          Name:
            NameFull: Thompson A
      – PersonEntity:
          Name:
            NameFull: Gillespie BS
      – PersonEntity:
          Name:
            NameFull: Denburg M
      – PersonEntity:
          Name:
            NameFull: Diva U
      – PersonEntity:
          Name:
            NameFull: Geetha D
      – PersonEntity:
          Name:
            NameFull: Greasley PJ
      – PersonEntity:
          Name:
            NameFull: Hladunewich MA
      – PersonEntity:
          Name:
            NameFull: Huizinga RB
      – PersonEntity:
          Name:
            NameFull: Inrig JK
      – PersonEntity:
          Name:
            NameFull: Komers R
      – PersonEntity:
          Name:
            NameFull: Laurin LP
      – PersonEntity:
          Name:
            NameFull: Little DJ
      – PersonEntity:
          Name:
            NameFull: Nachman PH
      – PersonEntity:
          Name:
            NameFull: Smith KA
      – PersonEntity:
          Name:
            NameFull: Walsh L
      – PersonEntity:
          Name:
            NameFull: Gibson KL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1523-6838
          Numbering:
            – Type: volume
              Value: 85
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: American journal of kidney diseases : the official journal of the National Kidney Foundation
              Type: main
ResultId 1